Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease

Gingival overgrowth (GO) is among one of the most important clinical features of gingival pathology frequently seen in periodontal clinic. Amlodipine is a comparatively new calcium channel blocker and is being used with increasing frequency in the management of hypertension and angina. A 48-year-old...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohan Kumar Pasupuleti, S. V. V. S. Musalaiah, M Nagasree, P Aravind Kumar
Formato:	article
Lenguaje:	EN
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2013
Materias:	acute myocardial infarction amlodipine angina gingival overgrowth Medicine R
Acceso en línea:	https://doaj.org/article/dfea384ca85d43ef9598a9474f1fd5a7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:dfea384ca85d43ef9598a9474f1fd5a7
record_format	dspace
spelling	oai:doaj.org-article:dfea384ca85d43ef9598a9474f1fd5a72021-12-02T17:05:51ZCombination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease2231-07702249-446410.4103/2231-0770.118462https://doaj.org/article/dfea384ca85d43ef9598a9474f1fd5a72013-07-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.4103/2231-0770.118462https://doaj.org/toc/2231-0770https://doaj.org/toc/2249-4464Gingival overgrowth (GO) is among one of the most important clinical features of gingival pathology frequently seen in periodontal clinic. Amlodipine is a comparatively new calcium channel blocker and is being used with increasing frequency in the management of hypertension and angina. A 48-year-old Indian woman who was on amlodipine for 3 years for hypertension reported to the department of periodontics with the complaint of swollen, un esthetic gums. The patient developed GO 6 months before her first visit to dental hospital. She developed GO very rapidly due to the increase in amlodipine dose due to the severe angina attack 6 months before and due to the use of cholesterol (CHO) lowering drug. The main aim of the case report is to study the severity of amlodipine induced GO in a patient with cardiovascular disease (CVD) and to identify the role of subgingival microorganisms on inflammatory gingival enlargement in the same patient. The severity and rapidity of gingival enlargement in this report could have been triggered by doubling the dose of amlodipine and concomitant use of CHO lowering drug.Mohan Kumar PasupuletiS. V. V. S. MusalaiahM NagasreeP Aravind KumarThieme Medical and Scientific Publishers Pvt. Ltd.articleacute myocardial infarctionamlodipineanginagingival overgrowthMedicineRENAvicenna Journal of Medicine, Vol 03, Iss 03, Pp 68-72 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	acute myocardial infarction amlodipine angina gingival overgrowth Medicine R
spellingShingle	acute myocardial infarction amlodipine angina gingival overgrowth Medicine R Mohan Kumar Pasupuleti S. V. V. S. Musalaiah M Nagasree P Aravind Kumar Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease
description	Gingival overgrowth (GO) is among one of the most important clinical features of gingival pathology frequently seen in periodontal clinic. Amlodipine is a comparatively new calcium channel blocker and is being used with increasing frequency in the management of hypertension and angina. A 48-year-old Indian woman who was on amlodipine for 3 years for hypertension reported to the department of periodontics with the complaint of swollen, un esthetic gums. The patient developed GO 6 months before her first visit to dental hospital. She developed GO very rapidly due to the increase in amlodipine dose due to the severe angina attack 6 months before and due to the use of cholesterol (CHO) lowering drug. The main aim of the case report is to study the severity of amlodipine induced GO in a patient with cardiovascular disease (CVD) and to identify the role of subgingival microorganisms on inflammatory gingival enlargement in the same patient. The severity and rapidity of gingival enlargement in this report could have been triggered by doubling the dose of amlodipine and concomitant use of CHO lowering drug.
format	article
author	Mohan Kumar Pasupuleti S. V. V. S. Musalaiah M Nagasree P Aravind Kumar
author_facet	Mohan Kumar Pasupuleti S. V. V. S. Musalaiah M Nagasree P Aravind Kumar
author_sort	Mohan Kumar Pasupuleti
title	Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease
title_short	Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease
title_full	Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease
title_fullStr	Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease
title_full_unstemmed	Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease
title_sort	combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease
publisher	Thieme Medical and Scientific Publishers Pvt. Ltd.
publishDate	2013
url	https://doaj.org/article/dfea384ca85d43ef9598a9474f1fd5a7
work_keys_str_mv	AT mohankumarpasupuleti combinationofinflammatoryandamlodipineinducedgingivalovergrowthinapatientwithcardiovasculardisease AT svvsmusalaiah combinationofinflammatoryandamlodipineinducedgingivalovergrowthinapatientwithcardiovasculardisease AT mnagasree combinationofinflammatoryandamlodipineinducedgingivalovergrowthinapatientwithcardiovasculardisease AT paravindkumar combinationofinflammatoryandamlodipineinducedgingivalovergrowthinapatientwithcardiovasculardisease
_version_	1718381821909008384

Combination of inflammatory and amlodipine induced gingival overgrowth in a patient with cardiovascular disease

Ejemplares similares